Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to -$86000.0.

  • RxSight's Change in Account Payables fell 30975.61% to -$86000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 million, marking a year-over-year decrease of 31741.07%. This contributed to the annual value of $946000.0 for FY2024, which is 2432.0% down from last year.
  • Per RxSight's latest filing, its Change in Account Payables stood at -$86000.0 for Q3 2025, which was down 30975.61% from -$3.7 million recorded in Q2 2025.
  • RxSight's 5-year Change in Account Payables high stood at $2.2 million for Q1 2025, and its period low was -$3.7 million during Q2 2025.
  • Moreover, its 5-year median value for Change in Account Payables was $116000.0 (2024), whereas its average is $95210.5.
  • The largest annual percentage gain for RxSight's Change in Account Payables in the last 5 years was 23265.86% (2022), contrasted with its biggest fall of 177920.79% (2022).
  • Quarter analysis of 5 years shows RxSight's Change in Account Payables stood at $101000.0 in 2021, then crashed by 1779.21% to -$1.7 million in 2022, then skyrocketed by 90.68% to -$158000.0 in 2023, then surged by 173.42% to $116000.0 in 2024, then tumbled by 174.14% to -$86000.0 in 2025.
  • Its Change in Account Payables stands at -$86000.0 for Q3 2025, versus -$3.7 million for Q2 2025 and $2.2 million for Q1 2025.